(3aS,7aS)-2-[2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)acetyl]-1,3,3a,4,6,7-hexahydropyrano[3,4-c]pyrrole-7a-carboxylic acid

C19H22N2O6 — CID 120628456

IUPAC(3aS,7aS)-2-[2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)acetyl]-1,3,3a,4,6,7-hexahydropyrano[3,4-c]pyrrole-7a-carboxylic acid
SMILESCC1Oc2ccccc2N(CC(=O)N2C[C@H]3COCC[C@@]3(C(=O)O)C2)C1=O
InChIInChI=1S/C19H22N2O6/c1-12-17(23)21(14-4-2-3-5-15(14)27-12)9-16(22)20-8-13-10-26-7-6-19(13,11-20)18(24)25/h2-5,12-13H,6-11H2,1H3,(H,24,25)/t12?,13-,19+/m0/s1
InChIKeyBFNZUOLOXZTYFM-MALMCIGFSA-N
MW374.39 g/mol
LogP0.75
Rot. Bonds3

About (3aS,7aS)-2-[2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)acetyl]-1,3,3a,4,6,7-hexahydropyrano[3,4-c]pyrrole-7a-carboxylic acid

(3aS,7aS)-2-[2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)acetyl]-1,3,3a,4,6,7-hexahydropyrano[3,4-c]pyrrole-7a-carboxylic acid (PubChem CID 120628456) has the molecular formula C19H22N2O6 and a molecular weight of 374.39 g/mol. Its IUPAC name is (3aS,7aS)-2-[2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)acetyl]-1,3,3a,4,6,7-hexahydropyrano[3,4-c]pyrrole-7a-carboxylic acid.

Molecular Properties

Compound Name(3aS,7aS)-2-[2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)acetyl]-1,3,3a,4,6,7-hexahydropyrano[3,4-c]pyrrole-7a-carboxylic acid
PubChem CID120628456
Molecular FormulaC19H22N2O6
Molecular Weight374.39 g/mol
Exact Mass374.15
IUPAC Name(3aS,7aS)-2-[2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)acetyl]-1,3,3a,4,6,7-hexahydropyrano[3,4-c]pyrrole-7a-carboxylic acid
SMILESCC1Oc2ccccc2N(CC(=O)N2C[C@H]3COCC[C@@]3(C(=O)O)C2)C1=O
InChIInChI=1S/C19H22N2O6/c1-12-17(23)21(14-4-2-3-5-15(14)27-12)9-16(22)20-8-13-10-26-7-6-19(13,11-20)18(24)25/h2-5,12-13H,6-11H2,1H3,(H,24,25)/t12?,13-,19+/m0/s1
InChIKeyBFNZUOLOXZTYFM-MALMCIGFSA-N
XLogP0.75
TPSA96.38 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds3
Heavy Atoms27
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500374.39
LogP ≤ 50.75
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze (3aS,7aS)-2-[2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)acetyl]-1,3,3a,4,6,7-hexahydropyrano[3,4-c]pyrrole-7a-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3aS,7aS)-2-[2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)acetyl]-1,3,3a,4,6,7-hexahydropyrano[3,4-c]pyrrole-7a-carboxylic acid?
The IUPAC name of (3aS,7aS)-2-[2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)acetyl]-1,3,3a,4,6,7-hexahydropyrano[3,4-c]pyrrole-7a-carboxylic acid (CID 120628456) is (3aS,7aS)-2-[2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)acetyl]-1,3,3a,4,6,7-hexahydropyrano[3,4-c]pyrrole-7a-carboxylic acid.
What is the SMILES notation for (3aS,7aS)-2-[2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)acetyl]-1,3,3a,4,6,7-hexahydropyrano[3,4-c]pyrrole-7a-carboxylic acid?
The canonical SMILES for (3aS,7aS)-2-[2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)acetyl]-1,3,3a,4,6,7-hexahydropyrano[3,4-c]pyrrole-7a-carboxylic acid is CC1Oc2ccccc2N(CC(=O)N2C[C@H]3COCC[C@@]3(C(=O)O)C2)C1=O.
What is the InChIKey of (3aS,7aS)-2-[2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)acetyl]-1,3,3a,4,6,7-hexahydropyrano[3,4-c]pyrrole-7a-carboxylic acid?
The InChIKey is BFNZUOLOXZTYFM-MALMCIGFSA-N. The full InChI is InChI=1S/C19H22N2O6/c1-12-17(23)21(14-4-2-3-5-15(14)27-12)9-16(22)20-8-13-10-26-7-6-19(13,11-20)18(24)25/h2-5,12-13H,6-11H2,1H3,(H,24,25)/t12?,13-,19+/m0/s1.
What are the key properties of (3aS,7aS)-2-[2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)acetyl]-1,3,3a,4,6,7-hexahydropyrano[3,4-c]pyrrole-7a-carboxylic acid?
(3aS,7aS)-2-[2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)acetyl]-1,3,3a,4,6,7-hexahydropyrano[3,4-c]pyrrole-7a-carboxylic acid has a molecular weight of 374.39 g/mol, XLogP of 0.75, 3 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (3aS,7aS)-2-[2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)acetyl]-1,3,3a,4,6,7-hexahydropyrano[3,4-c]pyrrole-7a-carboxylic acid is sourced from PubChem (CID 120628456), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).